-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GvNTfTa+bE/HByWUYyv1nXPeQ9HawcG1teHNs3ra6WHNoqk6L9lCreA1rjUL6eXL re3xPwlUSeW6XO2lZjfTiA== 0001266375-06-000077.txt : 20060706 0001266375-06-000077.hdr.sgml : 20060706 20060706172220 ACCESSION NUMBER: 0001266375-06-000077 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060703 FILED AS OF DATE: 20060706 DATE AS OF CHANGE: 20060706 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ISRAEL ROBERT J CENTRAL INDEX KEY: 0001250274 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23143 FILM NUMBER: 06948885 MAIL ADDRESS: STREET 1: 50 OXFORD DR CITY: MONTEBELLE STATE: NY ZIP: 10901 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2006-07-03 0 0000835887 PROGENICS PHARMACEUTICALS INC PGNX 0001250274 ISRAEL ROBERT J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 Sr. VP, Medical Affairs Common Stock 2006-07-03 4 M 0 5000 4 A 24822 D Common Stock 2006-07-03 4 S 0 5000 23.837 D 19822 D Common Stock 2006-07-03 4 A 0 6500 0 A 26322 D Common Stock 2006-07-03 4 M 0 2216 20.451 A 28586 D Common Stock 2006-07-03 4 F 0 2007 24.26 D 26579 D ESPP (right to buy) 20.451 2006-07-03 4 M 0 2216 0 D 2006-07-03 2006-07-03 Common Stock 2216 0 D ESPP (right to buy) 24.26 2006-07-03 4 A 0 584 0 A 2007-01-02 2007-01-03 Common Stock 584 584 D Non-Qualified Stock Option (right to buy) 4 2006-07-03 4 M 0 5000 0 D 2002-03-31 2007-04-01 Common Stock 5000 35000 D Non-Qualified Stock Option (right to buy) 24.26 2006-07-03 4 A 0 17500 0 A 2007-07-03 2016-07-03 Common Stock 17500 17500 D Sale under a 10b5-1 Plan, which was established in accordance with the policies and procedures of the Issuer. Restricted Stock shall be released in four equal installments, commencing one year from the transaction date. Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise. Includes shares of common stock acquired from the non-reportable exercise under a Qualified Employee Stock Purchase Plan. Granted under the Company's Non-Qualified Employeee Stock Purchase Plan. The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date. The number of shares exercised is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date. The option will be exercisable for that number of shares equal to the option amount (25% of the optionee's quarterly salary less $6,250) divided by the lesser of the market value of the common stock on the grant date or 85% of the market value on the day prior to the exercise date. The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer. The stock options become exercisable in four equal installments, commencing one year from the grant date. Robert J. Israel 2006-07-06 -----END PRIVACY-ENHANCED MESSAGE-----